13F Holdings
中文EN

MDCE Medical Care Technologies Inc.

Services-Business Services, NEC · OTC · SEC CIK 1404593 · Fiscal year ends 12/31

Financial factors as of 2012-09-30 (2012Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-64.4%
TTM EPS YoY100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-395.8%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets119.8%
Debt / equity—
Current ratio0.16x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.10x
Accruals ratio-354.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20112011-12-31FY20102010-12-31
Income statement
Revenue——
SG&A expense$876,034$800,119
Interest expense$487,167$341
Pretax income-$1.93M-$2.19M
Net income-$1.92M-$2.19M
EPS (basic)-0.01-0.02
EPS (diluted)-0.01-0.02
Balance sheet
Cash & equivalents$3,380$391
Current assets$45,062$6,891
PP&E, net$6,200$10,000
Intangibles$457,695$0
Total assets$513,921$16,891
Current liabilities$521,455$246,253
Total liabilities$652,409$246,253
Shareholders' equity-$138,488-$229,362
Shares outstanding328.90M161.01M
Cash flow statement
Operating cash flow-$371,920-$189,935
Capital expenditure$6,200$0
Free cash flow-$378,120-$189,935
Investing cash flow-$463,895$0
Financing cash flow$838,804$189,851
Depreciation & amortization$10,000$494,918
Stock-based compensation$788,186$1.48M

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.